Atherosclerosis Plus
@ATH_Plus
Followers
325
Following
231
Statuses
376
Official Twitter account of Atherosclerosis Plus, an open access journal published by Elsevier. Facebook Page: https://t.co/l2LEsUCyLV
Joined June 2021
Looking for some weekend reading? 🧐 Check out the abstracts from the HEART UK 37th Annual Medical & Scientific Conference! Packed with interesting insights!!! @ELS_Cardiology @society_eas
0
2
6
Missed this excellent review on 💊 Efficacy and safety of lipid-lowering therapies, with or without statins, in reducing cardiovascular risk? 🔍 A systematic review of RCTs not to be missed! @society_eas @ELS_Cardiology
0
7
25
HeFH followed up at a Lipid Clinic eat healthier than controls. Adherence to a healthy dietary pattern is associated with higher plasma levels of n-3 and n-6 PUFA, and lower levels of inflammatory markers @ELS_Cardiology @society_eas
1
5
16
Guess who's still the most cited paper in Atherosclerosis Plus? ➡️➡️➡️
0
2
3
RT @society_eas: Abstract submission for the 48th European Lipoprotein Club Meeting is now open! Don’t miss this opportunity to showcase yo…
0
7
0
Carotid plaque, not cIMT, is linked to poorer cognitive function, memory, executive function, and higher white matter lesion volume in older adults. Highlighting the brain-heart connection! @ELS_Cardiology @society_eas
2
14
42
#inclisiran in the real world: 67.7% of patients reached their LDL-C target within 1 month, and LDL-C dropped by 56.9% at 32 days, with significant reductions as early as day 7! 🔗 @ELS_Cardiology @society_eas
4
30
79
RT @EASCongress: Registration fees for #EASCongress2025 increase after 4 March 2025. The decision is simple - click this link to secure you…
0
3
0
Is very low #lipoprotein(a) linked to type 2 diabetes or #NAFLD? UK Biobank data show higher risks for both, with T2D risk influenced by statin use. However, Mendelian randomization suggests no causal relationship ➡️ @ELS_Cardiology @society_eas
1
5
27
Is severe hypertriglyceridemia linked to #ASCVD? Read this study on Ath Plus! ➡️ @ELS_Cardiology @society_eas
5
7
24
Atorvastatin metabolites show promise as biomarkers for diagnosing clinical #statinintolerance in patients with #SAMS
@society_eas @ELS_Cardiology
3
10
31
RT @society_eas: Join us for an exclusive episode of AtheroTalk with Prof. Paul Ridker, recipient of the Anitschkow Prize 2025. Discover hi…
0
12
0
Children with #FH show rising #lipoprotein(a) levels with age, with girls having higher levels than boys. Nearly 1 in 3 had a >50% increase over ~9 years. @ELS_Cardiology @society_eas
1
8
19
#GLP1RA show promise in stabilizing atherosclerotic plaques in T2D patients. A 1-year use was linked to significant regression of lipid-rich plaques, supporting their role in cardiovascular protection. @ELS_Cardiology @society_eas
0
6
25
Switching from lipoprotein apheresis to evolocumab lowers arachidonic acid and its pro-inflammatory metabolites, potentially adding cardiovascular benefits @ELS_Cardiology @society_eas
0
3
9
SMC-specific deletion of Ccl2 in mice does not impact atherosclerotic plaque size or composition, suggesting SMC-derived CCL2 is not critical for early atherogenesis. ➡️ @ELS_Cardiology @society_eas
3
2
8
Adding bempedoic acid + ezetimibe (FDC) to statins helps 79% of ASCVD patients achieve LDL-C goals, outperforming current care standards. It also reduces the need for PCSK9 inhibitors. Simulation insights➡️➡️ @ELS_Cardiology @society_eas
0
29
72
📖 Relive Atherosclerosis Plus 2024! Take a look back at the groundbreaking research we published this year. Don’t miss the highlights and key discoveries! 🔍 Explore the papers: #AtherosclerosisPlus #ResearchHighlights
0
1
2
RT @ELS_Cardiology: This paper evaluates the existing evidence on cardiovascular care of cancer patients before cardiotoxic cancer therapy…
0
3
0
Kick off 2025 by sharing your research with the world. Submit your manuscript to Atherosclerosis Plus and join us in advancing science! Find more details at: @ELS_Cardiology @society_eas 📑📑📑
0
1
1